^
Association details:
Biomarker:ASNS underexpression
Cancer:Ovarian Cancer
Drug:IPN60090 (Glutaminase inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Title:

New Therapy for Lung and Ovarian Cancer Advances to Early-stage Clinical Development

Published date:
04/27/2020
Excerpt:
...low expression of the metabolic protein asparagine synthetase (ASNS) in ovarian cancers predicts response to IPN60090 in preclinical models.